1. ALLA AKTIER
  2. NYHETER
  3. NANOLOGICA

Nanologica

Nyheter Nanologica Nyheter alla bolag

Nanologica AB (publ) Receives Order of appx. SEK 1 Million In China

MAR

Nanologica has received an order for the company's silica-based purification media NLAB Saga® from a new distribution partner in China. The order relates to sampling NLAB Saga® to pharmaceutical manufacturers.

"This order is a result of our production now being stable. Going forward we will have larger volumes of our silica products, which is why we are now increasing our sales efforts in China. We will continue to handle many customers ourselves, but also work together with partners to better serve more customers. This order allows us to get started with more customers faster," comments Nanologica's CEO Andreas Bhagwani.
 
The order is expected to be delivered in the fourth quarter.

For further information, please contact
Johanna Johansson
Director IR, Communications and Marketing
johanna.johansson@nanologica.com
+46 72 211 21 90

About Nanologica AB (publ)
Nanologica is a Swedish life science tools company that develops, manufactures, and sells advanced consumables to pharmaceutical manufacturers. Nanologica’s products are specially developed for the purification of peptide drugs, such as insulin and GLP-1 analogues. Due to effective purification and a long lifetime for the products, they can increase productivity and reduce costs for pharmaceutical manufacturers. Nanologica operates in a global niche market that is growing as a result of increased demand for drugs for the treatment of diabetes and obesity. The company's mission is to increase access to cost-effective drugs through its purification products and thereby contribute to more patients around the world having access to life-saving treatments. The company is headquartered in Södertälje and Nanologica's share (NICA) is listed for trading on Nasdaq Stockholm Main Market. For further information, please visit www.nanologica.com.

This information is information that Nanologica AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-10-22 09:41 CEST.

Attachments
Nanologica AB (publ) Receives Order of appx. SEK 1 Million In China

Datum 2025-10-22, kl 09:41
Källa MFN
Bifogade filer
Nanologica AB (publ) Receives Order of appx. SEK 1 Million In China
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!